Pierre Foidart
4PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 02, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies.Marie-Anne Goyette, Christopher Graser, Marco Seehawer
|Mar 21, 2025
Is adjuvant olaparib standard of care in all high-risk HER2-negative early breast cancer presenting <i>gBRCA1/2</i> mutations?Pierre Foidart, Guy Jerusalem
|Sep 07, 2023
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.Maša Alečković, Zheqi Li, Ningxuan Zhou
|Feb 21, 2020
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.Florence Coussy, Rania El-Botty, Sophie Château-Joubert
Pageof 1
Frequent Collaborators
2 joint publications
Kornelia Polyak
2 joint publications
Zheqi Li
1 joint publications
Florence Coussy
1 joint publications
Rania El-Botty
1 joint publications
Sophie Leboucher
1 joint publications
Thibaut Larcher
1 joint publications
Sophie Vacher
1 joint publications
Laetitia Fuhrmann
1 joint publications
Franziska Michor
1 joint publications
Jos Jonkers
